Devyser launches the first IVDR compliant NGS assay for thalassemia and sickle cell disease testing
Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing...
News | April 15, 2019
Devyser is extremely proud to have been recognized as one of Sweden’s best workplaces (Small Organisations). Across all categories Devyser was the only nominated workplace from the biotech/medtech industry in Sweden. This is a wonderful recognition of the teamwork that our colleagues exhibit every day, thank you to all who make Devyser the wonderful workplace that it is!
Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing...
Read More
Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announces that it has...
Read More
Devyser today announced that it entered a strategic agreement with Illumina, a global leader in DNA...
Read More
Devyser is proud to announce that the company has been awarded a tender by Oslo University Hospital...
Read More